Floatz logo

rtl1000

Multiple Sclerosis, Chronic Progressive

Artielle ImmunoTherapeuticsprotein_peptidePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

12 Active assets in the Multiple Sclerosis, Chronic Progressive cohort.

Asset / SponsorPhaseRating
D-thioctic acid
Rebecca Spain
Phase 2/3BB
Cyclophosphamide
Bruce Cree
Phase 3BB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Centre Hospitalier de PAU
Phase 2B
Masitinib
AB Science
Phase 3B
Cladribine
Queen Mary University of London
Phase 2/3B

View all 29 →

Same molecule, other indications

rtl1000 is also rated in:

relapsing-remitting multiple sclerosisDormant
CC
Indicative ·
41 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →